Anxiety Disorder and Depression Treatment Market is expected to reach US$ 13.71 Bn. at a CAGR of 2.6% during the forecast period 2029.
Anxiety Disorder and Depression Treatment Market Overview:
Anxiety Disorder and Depression Treatment Market Segmentation:
The drug class, therapies, and application segments make up the global market for the treatment of anxiety disorders and depression. Benzodiazepines, Atypical Antipsychotics, Anticonvulsants, Beta-Blockers, Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs), Monoamine Oxidase Inhibitors (MAOIs), Antidepressant Drugs, Tricyclic Antidepressants (TCAs), and Others are listed by drug class. Of these, the market for the treatment of anxiety disorders and depression worldwide is anticipated to be dominated by the Selective Serotonin Reuptake Inhibitors (SSRIs) segment. By preventing some brain nerve cells from reabsorbing, or reuptaking, serotonin, SSRIs reduce symptoms. More serotonin is thereby available, which elevates mood. When compared to tricyclic antidepressants, SSRIs (citalopram, escitalopram, fluoxetine, paroxetine, and sertraline) typically caused fewer side effects. By Therapies Deep Brain Stimulation, Transcranial Magnetic Stimulation, Cognitive Behavior Therapy, Electroconvulsive Therapy (ECT), Psychotherapy.
Anxiety Disorder and Depression Treatment Market Size and Forecast, by Drug class (2022-2029)
1. selective Serotonin Reuptake Inhibitors (SSRIs)
2. Antidepressant Drugs
3. Tricyclic Antidepressants (TCAs)
4. Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
5. Monoamine Oxidase Inhibitors (MAOIs)
6. Benzodiazepines
7. Atypical Antipsychotics
8. Anticonvulsants
9. Beta-Blockers
Anxiety Disorder and Depression Treatment Market Size and Forecast, by Therapies (2022-2029)
1. Electroconvulsive Therapy (ECT)
2. Cognitive Behavior Therapy (CBT)
3. Psychotherapy
4. Deep Brain Stimulation
5. Transcranial Magnetic Stimulation (TMS)
6. Cranial electrotherapy stimulation (CES)
Anxiety Disorder and Depression Treatment Market Size and Forecast, by Application (2022-2029)
3. Phobia
3. Major Depressive Disorder
3. Obsessive Compulsive Disorder (OCD)
4. Post-traumatic stress disorder
5. Others
Anxiety Disorder and Depression Treatment Market Size and Forecast, by Region (2022-2029)
1. North America
2. Europe
3. Asia Pacific
4. Middle East and Africa
5. South America
For any Queries Linked with the Report, Ask an Analyst
@ https://www.maximizemarketresearch.com/request-sample/39288
Anxiety Disorder and Depression Treatment Market Key Players: The key players are
• Eli Lilly and Company,
• Forest Laboratories, Inc.,
• AstraZeneca PLC,
• Sanofi-Aventis,
• Merck & Co., Inc.,
• Pfizer, Inc.,
• GlaxoSmithKline plc.
• Johnson & Johnson
• H. Lund beck A/S,
• Forest Laboratories, Inc.,
• Sanofi-Aventis
• Bristol-Myers Squibb Company
• Novartis AG
• Mylan N.V
• Glenmark Life Sciences Limited
• Lupin Limited
• Amneal Pharmaceuticals Inc.
• Sun Pharmaceutical Industries Ltd.
• Sumitomo Dainippon Pharma Co. Ltd.
• Intas Pharmaceuticals Ltd.
For any Queries Linked with the Report, Ask an Analyst
Anxiety Disorder and Depression Treatment Market Regional Analysis:
The Anxiety Disorder and Depression Treatment market prediction research is created after a thorough examination of many geographical areas, including Asia-Pacific, Europe, North America, and the rest of the globe. North America has the greatest power over the Anxiety Disorder and Depression Treatment market share and will continue to be a major shareholder in the global Anxiety Disorder and Depression Treatment market.
COVID-19 Impact Analysis on Anxiety Disorder and Depression Treatment Market: The COVID-19 impact on the Anxiety Disorder and Depression Treatment market is also included in the report
Key Questions Answered in the Anxiety Disorder and Depression Treatment Market Report are:
- What will be the CAGR of the Anxiety Disorder and Depression Treatment market during the forecast period?
- Which segment emerged as the leading segment in the Anxiety Disorder and Depression Treatment market?
- Which are the prominent players in the Anxiety Disorder and Depression Treatment market?
About Us